US FDA Kills ISO Voluntary Audit Program As MDSAP Efforts Accelerate
This article was originally published in Clinica
The US FDA has terminated its three-year-old ISO 13485 voluntary audit program, which gave medtech companies the chance for a one-year reprieve from an FDA inspection, to put all attention on the global Medical Device Single Audit Program.
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.